AZN vs PTC · P/E 28, $288.38B cap vs P/E 48, rev $2.74B
AstraZeneca PLC (AZN) versus PTC Inc (PTC) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
PTC Inc (PTC) is a software - application company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported PTC revenue for 2025-09-30 was $2.74B. Net income was $734.0M. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
Not investment advice. Open the AZN and PTC stock pages for the full models.
Not investment advice.